ENST00000569107.6:c.4760G>A

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The ENST00000569107.6(CACNA1H):​c.4760G>A​(p.Ser1587Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,450,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

CACNA1H
ENST00000569107.6 missense

Scores

5
1
1
Splicing: ADA: 1.000
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 9.58

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 34 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000569107.6 linkc.4760G>A p.Ser1587Asn missense_variant Exon 25 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000348261.11 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 34 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000711493.1 linkc.4795+1G>A splice_donor_variant, intron_variant Intron 25 of 33 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 33 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.4697+1G>A splice_donor_variant, intron_variant Intron 25 of 34 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 34 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.4720+1G>A splice_donor_variant, intron_variant Intron 25 of 34 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 33 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.4720+1G>A splice_donor_variant, intron_variant Intron 25 of 33 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 35 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 34 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 35 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 34 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 33 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 36 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*729+1G>A splice_donor_variant, intron_variant Intron 25 of 33 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.4697+1G>A splice_donor_variant, intron_variant Intron 25 of 34 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*2610+1G>A splice_donor_variant, intron_variant Intron 25 of 34 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4144+1G>A splice_donor_variant, intron_variant Intron 24 of 33 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 35 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 34 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 35 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 35 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 35 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 34 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 36 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 35 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.4759+1G>A splice_donor_variant, intron_variant Intron 25 of 34 ENSP00000518777.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000422
AC:
1
AN:
236870
AF XY:
0.00000770
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000571
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000138
AC:
2
AN:
1450504
Hom.:
0
Cov.:
35
AF XY:
0.00000139
AC XY:
1
AN XY:
721662
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33366
American (AMR)
AF:
0.00
AC:
0
AN:
44524
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26044
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39650
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86108
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4710
European-Non Finnish (NFE)
AF:
9.01e-7
AC:
1
AN:
1110444
Other (OTH)
AF:
0.00
AC:
0
AN:
60072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Mar 04, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CACNA1H cause disease. This variant has not been reported in the literature in individuals with CACNA1H-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 25 of the CACNA1H gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.24
D
BayesDel_noAF
Pathogenic
0.29
CADD
Pathogenic
34
DANN
Uncertain
0.99
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.93
FATHMM_MKL
Pathogenic
0.98
D
PhyloP100
9.6
GERP RS
4.1
Mutation Taster
=5/95
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.94
SpliceAI score (max)
0.98
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.22
Position offset: 32
DS_DL_spliceai
0.98
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1406256818; hg19: chr16-1262139; COSMIC: COSV61992838; COSMIC: COSV61992838; API